Due to storm damage, our Largo office is temporarily closed; however, you can still see your regular provider at our PTAK office at 430 Morton Plant St., #208 in Clearwater. Click for details

Our Pasadena office is temporarily closed; however you can still see your regular provider at our St. Petersburg 38th Avenue office. Click for details

Our pharmacy has temporarily relocated to a new address and some prescriptions may be delayed. Click for details

Skip to content

Staying at the Forefront Through Clinical Research

The newest treatment advances come through clinical research trials. By conducting these research trials, our patients have access to expert knowledge and promising treatments before they are widely available.

Your participation means you’ll receive regular and careful medical attention from AUI research teams including urologists and other medical specialists. And you’ll play an important role in advancing medicine.

Clinical Trial Sponsors

Partner with AUI for your next Clinical Research Trial. For details, call the number listed for each location.

Clinical Research Trials at AUI

Every clinical research trial described below follows strict guidelines to ensure your safety. Ask your doctor if there’s a trial that is right for you. Or call the number listed after each trial description.

AUI Daytona

Clinical trials for patients with Interstitial Cystitis:

Ironwood C3300-201

Ironwood Pharmaceuticals, Inc.

NCT05740007

A Phase 2, Randomized, Double -blind, Placebo-controlled, Adaptive study to evaluate the Efficacy, Safety, and Tolerability of 2 Dose levels of IW-3300 administered rectally for 12 weeks to treat bladder pain in subjects with Interstitial Cystitis/Bladder Pain Syndrome.

Learn More

Clinical trials for patients with Prostate Cancer:

Dendreon P23-1

Dendreon Pharmaceuticals

NCT06134232

An Open-Label, Multicenter Study of Subjects with Metastatic Castrate-Resistant Prostate Cancer Treated with Provenge and Boosted with a Single Infusion of Sipuleucel-T to Measure Immune Response.

Learn More

ECT2023-001 EPI-Bridging Study

exosomedx

The purpose of this study is to evaluate workflow process improvements to the ExoDx prostate test using prospective urine collection in the intended use population.

Libertas 56021927PCR3020

Janssen Pharmaceuticals

NCT05884398

A Phase 3, Open-Label, Randomized, Prospective Study of Apalutamide with Continued Versus Intermittent Androgen-Deprivation Therapy (ADT) following PSA Response in Participants with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

Learn More

Mdx Health – Confidence

The purpose of this study is to assess current clinical practices for managing patients with one or more cancer-negative prostate biopsies, and to determine the impact and clinical utility of Confirm mdx when used to manage these patients.

MVT-601-058

Myovant Sciences

NCT05467176

A Multi-Center, Prospective, Observational Study of Patients being treated with ORGOVYX

Learn More

For more information or to enroll in one of these trials, call our Daytona Clinical Research Department at 386-239-8535 or 386-236-2676.

AUI Largo (Pinellas County)

Clinical trials for patients with Bladder Cancer:

PIVOT-006

GC Oncology

This is an open-label, Phase 3 study designed to assess the recurrence free survival rate (RFS) of TURBT followed by adjuvant Cretostimogene versus TURBT followed by observation for the treatment of participants with Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR-NMIBC).

Clinical trials for patients with Prostate Cancer:

Dendreon P23-1

Dendreon Pharmaceuticals

NCT06134232

An Open-Label, Multicenter Study of Subjects with Metastatic Castrate-Resistant Prostate Cancer Treated with Provenge and Boosted with a Single Infusion of Sipuleucel-T to Measure Immune Response.

Learn More

For more information or to enroll in one of these trials, call our Largo (Pinellas County) Clinical Research Department at 727-441-1508 ext 119.

AUI Oxford

Clinical trials for patients with Prostate Cancer:

Dendreon P23-1

Dendreon Pharmaceuticals

NCT06134232

An Open-Label, Multicenter Study of Subjects with Metastatic Castrate-Resistant Prostate Cancer Treated with Provenge and Boosted with a Single Infusion of Sipuleucel-T to Measure Immune Response.

Learn More

Mdx Health – Confidence

The purpose of this study is to assess current clinical practices for managing patients with one or more cancer-negative prostate biopsies, and to determine the impact and clinical utility of Confirm mdx when used to manage these patients.

For more information or to enroll in one of these trials, call our Ocala Clinical Research Department at 352-504-4608.